Piramal to encourage green chemistry at CPhI

Piramal Enterprises' pharma solutions division will call on pharma companies to start complementing the principles of Quality by Design (QbD) to advance product and process quality at CPhI

The company has launched a series of green chemistry initiatives and is asking all its partners to evaluate the greenness of the chemical pathways they are using in any project.  

Vivek Shama, CEO of pharma solutions, Piramal Enterprises, said: “Green Chemistry by design (GCbD) presents us with a great opportunity to look at the bigger picture during route scouting and move ahead with green chemistry principles.

“I am sure that further down the line the FDA will look at bringing in these principles more formally, but as an industry we should be taking action and doing this now. 

“We need to start the GCbD process  early – not after a NDA or DMF has been filed, but as early as Phase I for innovators and as early as NDA approval for Generic players.

“This is where the Greener routes are established, after which they tend to remain with the product through its life cycle, and that is where the fundamental change needs to occur.

“At CPhI Worldwide, Piramal is urging its partners and the wider industry to take up greener, and often cost effective routes to market, as we believe that as an industry we have a greater responsibility to reduce our carbon footprint while also assisting patients.”

At CPhI Piramal will be looking for new partners to commercialise these waste-reduction technologies.